Results 171 to 180 of about 246,153 (308)

HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaques. [PDF]

Nat Commun
Bissa M, Rahman MA, Schifanella L, Goldfarbmuren KC, Silva de Castro I, Woode EK, Gutowska A, Doster MN, Brown S, Sarkis S, Kanchetty NR, Pise-Masison CA, Washington-Parks R, McKinnon K, Basu S, Kim J, Alving R, Paquin-Proulx D, N'guessan KF, Shen X, Montefiori DC, Cardozo T, Matyas GR, Rao M, Franchini G.   +24 more
europepmc   +1 more source

HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions

Transplant Infectious Disease, EarlyView.
Risk mitigation strategies, including donors/recipients screening, DNAemia monitoring in recipients at risk, CNI‐to‐mTOR inhibitors switch, antivirals, and rituximab for KICS, may mitigate the impact of HHV‐8/KSHV infection in SOT. This review provides an update on KICS, identifies research gaps, and summarizes advances in screening and management ...
Alessandra Mularoni, Andrea Cona, Malgorzata Mikulska, Francesca Pecoraro, Carlotta Piazza, Elda De Vita, Giada Pietrosi, Matteo Bulati, Tiziana Lazzarotto, Mario Luppi   +9 more
wiley   +1 more source

Vaccine Candidates Designed to Prevent Enterotoxigenic Escherichia coli Diarrhoea: A Scoping Review of Clinical Trials Evaluating Vaccine Candidates in Development

Tropical Medicine &International Health, EarlyView.
ABSTRACT Objectives The primary objectives of this study are to (1) summarise the current landscape of ETEC vaccine development by describing, characterising and comparing ETEC vaccine candidates in clinical development, (2) assess key characteristics of the phases 1, 2 and 3 clinical trials that have been designed to evaluate ETEC vaccines in ...
Vaidehi Nafade, Naheemot O. Sule, Yang Zhang, Angelina Sassi, Nicole E. Basta   +4 more
wiley   +1 more source

The experience of trial participation disclosure among sex workers in a phase IIb HIV vaccine trial: A qualitative study in urban Tanzania. [PDF]

PLOS Glob Public Health
Ambikile JS, Tarimo EAM, Iseselo MK, Lukumay G, Munseri P, Bakari M, Lyamuya E, Aboud S, Kawuma R, Seeley J.   +9 more
europepmc   +1 more source

Systems Vaccinology in HIV Vaccine Development. [PDF]

Vaccines (Basel), 2022
Zhang J, Askenase P, Crumpacker CS.
europepmc   +1 more source

Safety and immunogenicity of an HIV vaccine trial with DNA prime and replicating vaccinia boost. [PDF]

Signal Transduct Target Ther
Liu Y, Lv W, Shan P, Li D, Wu YQ, Wang YC, Li YY, Liu Q, Wang JS, Hao YL, Liu Y, Huang WJ, Ren L, Wang SH, Li TS, Xu J, Shao YM.   +16 more
europepmc   +1 more source

Engaging an HIV vaccine target through the acquisition of low B cell affinity. [PDF]

Nat Commun, 2023
Ronsard L, Yousif AS, Nait Mohamed FA, Feldman J, Okonkwo V, McCarthy C, Schnabel J, Caradonna T, Barnes RM, Rohrer D, Lonberg N, Schmidt A, Lingwood D.   +12 more
europepmc   +1 more source

High-throughput single-cell transcriptome analysis of immune cells from HIV-1 infected individuals before and after therapy

Journal of Virus Eradication, 2017
T. Bradley, C. Hart, B. Hora, J. Pollara, E.P. Browne, M. Anthony Moody, G. Ferrari, D. Margolis, B.F. Haynes   +8 more
doaj   +1 more source

Deciphering HIV vaccine-induced antibody response according to ethnicity. [PDF]

AIDS
Lin LY, Ferte T, Chachage M, Casteano C, Laumond G, Schmidt S, Tahar O, Carapito R, Bekker LG, Churchyard G, Keefer M, Moodie Z, Viegas E, Geldmacher C, Lhomme E, Moog C.   +15 more
europepmc   +1 more source

Iterative hypothesis testing in HIV vaccine research: moving towards success. [PDF]

J Int AIDS Soc, 2023
Anklesaria P, Russell ND.
europepmc   +1 more source